Combination chemotherapy with 5-fluorouracil, cisplatin and paclitaxel for pretreated patients with advanced gastric cancer

K Yamaguchi, S Nakagawa, H Yabusaki… - Anticancer …, 2007 - ar.iiarjournals.org
Background: Paclitaxel, 5-FU and cisplatin are effective against gastric cancer, but the
optimal regimen for combined chemotherapy with these drugs remains unclear. This …

Phase II study of paclitaxel and carboplatin in advanced gastric cancer previously treated with 5-fluorouracil and platinum

HM Chang, TW Kim, BY Ryu, SJ Choi… - Japanese journal of …, 2005 - academic.oup.com
Background: The combination of paclitaxel and carboplatin has been used to treat patients
with many types of tumor, including gastric cancer. We evaluated the efficacy and safety of …

Feasibility study of triplet combination chemotherapy of paclitaxel, cisplatin and S-1 for advanced gastric cancer

K Fujitani, H Hasegawa, M Hirao, Y Kurokawa… - Anticancer …, 2011 - ar.iiarjournals.org
Background: Docetaxel combined with cisplatin and 5-fluorouracil (5-FU) is active in
advanced gastric cancer, but not generally accepted because of its substantial toxicities. We …

A phase II study of paclitaxel combined with infusional 5-fluorouracil and low-dose leucovorin for advanced gastric cancer

CK Im, HC Jeung, SY Rha, NC Yoo, SH Noh… - Cancer chemotherapy …, 2008 - Springer
Purpose The aim of this study was to investigate the efficacy and safety of the combination
chemotherapy of paclitaxel, infusional 5-fluorouracil (5-FU) and leucovorin (FLT regimen) in …

Paclitaxel, 5-fluorouracil, and leucovorin combination chemotherapy as first-line treatment in patients with advanced gastric cancer

WC Que, YF Huang, XY Lin, YQ Lan, XY Gao… - Anti-Cancer …, 2019 - journals.lww.com
The aim of this retrospective analysis was to evaluate the efficacy and toxicity of combination
chemotherapy with paclitaxel, 5-fluorouracil, and leucovorin (TFL) as first-line treatment in …

A phase I study of paclitaxel and 5-fluorouracil in advanced gastric cancer

S Cascinu, R Ficarelli, MAA Safi, F Graziano… - European Journal of …, 1997 - Elsevier
This is a phase I study to determine the maximum tolerated dose (MTD) and toxicity of a
combination of paclitaxel and 5-Fluorouracil (5-FU) in advanced gastric cancer patients. The …

[HTML][HTML] A phase II trial of paclitaxel, 5-fluorouracil (5-FU) and cisplatin in patients with metastatic or recurrent gastric cancer

GH Kang, GS Kim, HR Lee, YJ Yuh… - Cancer Research and …, 2008 - ncbi.nlm.nih.gov
Purpose We wanted to assess the effectiveness and safety of combination chemotherapy
with paclitaxel, 5-fluorouracil (5-FU) and cisplatin for treating advanced gastric cancer …

Combination chemotherapy with paclitaxel and oxaliplatin as first-line treatment in patients with advanced gastric cancer

Y Lan, L Kong, X Lin, Q Xu, X Gao, R Wu… - Cancer Chemotherapy …, 2018 - Springer
Purpose This study is a retrospective analysis evaluating the efficacy and toxicity of
combination chemotherapy with Paclitaxel (PTX) and Oxaliplatin (OXA) as first-line treatment …

[HTML][HTML] Phase II study of paclitaxel, cisplatin, and 5-fluorouracil combination chemotherapy in patients with advanced gastric cancer

J Hwang, SH Cho, HJ Shim, SR Lee… - Journal of Korean …, 2008 - ncbi.nlm.nih.gov
This phase II study evaluated the efficacy and safety of combination chemotherapy with
paclitaxel, cisplatin, and 5-fluorouracil (5-FU) in advanced gastric cancer. Patients with …

Paclitaxel, 5‐fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma

YH Kim, SW Shin, BS Kim, JH Kim… - … Journal of the …, 1999 - Wiley Online Library
BACKGROUND Although the clinical efficacy of paclitaxel in the treatment of gastric
carcinoma has not been clearly defined, recent reports have suggested a possible role in …